Background {#Sec1}
==========

Wheat (*Triticum aestivum*) is one of the most important crops in the world. Take-all of wheat, caused by the soil-borne fungus *Gaeumannomyces graminis* var. *tritici*, is one of the most serious and widespread root diseases \[[@CR1], [@CR2]\]. The pathogen infects the roots of susceptible plants, resulting in black necrotic, plant stunting, white heads, and etc. \[[@CR3], [@CR4]\]. It reduces the grain yield from 20 % up to 50 %. Unfortunately, the control of take-all is still a huge problem. And the application of agrochemicals is currently the most effective method \[[@CR5]\]. However, existing chemical control agents, such as silthiopham, were not financially affordable for the control of wheat take-all \[[@CR6]\]. Hence, it is necessary to develop effective and inexpensive agents to replace the conventional agrochemicals.

Introducing active groups of natural products is an effective and important method for the discovery of new agrochemicals \[[@CR7], [@CR8]\]. 1,2,3,4-tetrahydroquinoline (THQ), widely existing in natural products \[[@CR9], [@CR10]\], has been often reported for its favorable bioactivities, such as anticancer \[[@CR11], [@CR12]\], antibacterial \[[@CR13], [@CR14]\], antifungal \[[@CR15], [@CR16]\] activities, and so on. For example, aspernigerin (Fig. [1](#Fig1){ref-type="fig"}), isolated from the extract of a culture of *Aspergillus niger* IFB-E003, exhibited favorable cytotoxic to the tumor cell lines \[[@CR17]\], and certain fungicidal activities, insecticidal activities and herbicidal activities \[[@CR18], [@CR19]\].Fig. 1The structures of aspernigerin and pyraclostrobin

In recent years, pyrazole derivatives have attracted tremendous attention owing to their excellent bioactivities \[[@CR20]--[@CR22]\]. Pyraclostrobin (Fig. [1](#Fig1){ref-type="fig"}) discovered by BASF is a commercial fungicide containing pyrazole structure. It came to the market in 2002. Given its wide fungicidal spectrum, pyraclostrobin had achieved a total sale of \$800 million in 2012, ranked the second in the world. \[[@CR23]\]. Besides, pyrazole derivatives were also reported to possess insecticidal activities \[[@CR24], [@CR25]\], herbicidal activities \[[@CR26]\], and anticancer activities \[[@CR27], [@CR28]\].

It is an effective method to develop new green agrochemicals by introducing active groups of natural products to known active sub-structures. As above mentioned, THQ is an important active group of natural products. In order to find highly biologically active lead compounds with simple structures, THQ was introduced to the known active sub-substructure of pyrazole compounds using intermediate derivatization methods (IDM) \[[@CR29]\]. A series of pyrazole derivatives containing 1,2,3,4-tetrahydroquinoline were synthesized, and their activities were evaluated in this study. Biological assays revealed that some compounds exhibited good fungicidal activities. Especially, they displayed excellent activities against *G. graminis* var. *tritici*.

Results and discussion {#Sec2}
======================

Synthesis {#Sec3}
---------

The synthetic procedure of intermediates **3a--3n** is shown in Scheme [1](#Sch1){ref-type="fig"} \[[@CR30]\]. By using Claisen condensation in the presence of sodium ethoxide, substituted ketone **1** reacted with diethyl oxalate to afford the β-ketoester intermediate **2**. With glacial acetic acid acidification, compound **2** was reacted with substituted hydrazine via Knorr reaction to obtain the intermediates **3a--3n**. This method has two advantages. Firstly, ethyl 5-pyrazolecarboxylate compounds were synthesized simply through a "one-pot" process. Secondly, the reaction proceeds well at ambient temperature.Scheme 1Synthetic route of intermediates **3a--3n**. Reagents and conditions: (a) CH~3~CH~2~ONa, CH~3~CH~2~OH, diethyl oxalate, room temperature (r.t.), 2 h; (b) glacial acetic acid, r.t., 0.5 h; substituted hydrazine, r.t., overnight

Synthesis of compounds **3o--3p** is carried out following a different method \[[@CR31], [@CR32]\] and the procedure was shown in Scheme [2](#Sch2){ref-type="fig"}. 2,3-dichloropyridine **4** reacted with hydrazine hydrate (80 %) to yield the intermediate **5**, which underwent cyclization with diethyl maleate to give the intermediate **6**. The reaction of **6** with phosphorus oxychloride or phosphorus oxybromide afforded the chlorine or bromine substituted compound **7,** which was then oxidized to give the intermediates **3o--3p**.Scheme 2Synthetic route of intermediates **3o--3p**. Reagents and conditions: (a) NH~2~NH~2~·H~2~O (80 %), reflux, 5 h; (b) CH~3~CH~2~ONa, CH~3~CH~2~OH, reflux, 10 min, then diethyl maleate, reflux, 30 min; (c) POCl~3~ or POBr~3~, CH~3~CN, reflux, 5 h; (d) H~2~SO~4~, CH~3~CN, r.t., 10 min, then K~2~S~2~O~8~, reflux, 4 h

General synthetic procedure of title compounds **10a--10p** is shown in Scheme [3](#Sch3){ref-type="fig"}. The saponification of the ester intermediate **3** afforded the substituted-1*H*-pyrazole-5-carboxylic acid **8** \[[@CR33]\]. The title compounds **10** were prepared by the amidation of compounds **9** and 1,2,3,4-tetrahydroquinoline (THQ) \[[@CR34]\].Scheme 3Synthetic route of the target compounds **10**. Reagents and conditions: (a) NaOH aqueous solution, r.t., 3 h, then HCl acidification; (b) SOCl~2~, toluene, reflux, 3 h; (c) 1,2,3,4-tetrahydroquinoline, pyridine, CH~2~Cl~2~, r.t., 1 h

The structures of all the title compounds were confirmed by ^1^H NMR, ^13^C NMR, IR spectra and HRMS or elemental analysis and the relevant data could be found in the Additional file [1](#MOESM1){ref-type="media"}. Compound **10a** was taken as an example to analyze the ^1^H NMR spectra data. Four protons of the benzene ring were observed at *δ* 7.18--6.87. A single peak at *δ* 5.76 was due to the proton at the 4-position of the parazole ring. Two protons at the 2-position of THQ were observed at *δ* 3.90 with *J* = 6.5 Hz as a triple peak, and the other triple peak at *δ* 2.82 with *J* = 6.6 Hz was due to the protons at the 4-position of THQ. Two protons at the 3-position of THQ was showed at *δ* 2.03 with *J* = 6.6 Hz as pentaploid peaks. The chemical shifts as single peaks were observed at *δ* 3.87 and 2.15 due to the protons of N-CH~3~ and CH~3~ at the 3-position of the parazole ring respectively.

In order to further confirm the structure of the title compounds, a single crystal of **10g** (R^1^ = Ph, R^2^ = Me) was prepared for the X-ray diffraction. The single crystal was obtained by slow evaporation of a solution of compound **10g** in ethyl acetate at room temperature. As shown in Fig. [2](#Fig2){ref-type="fig"}, the crystal data for **10g**: orthorhombic, space group P2~1~2~1~2~1~ (no. 19), *a* = 8.3512(9) Å, *b* = 12.5600(13) Å, *c* = 15.3638(16) Å, *V* = 1611.5(3) Å^3^, *Z* = 4, *T* = 180.01(10) K, μ(Mo Kα) = 0.083 mm^−1^, *Dcalc* = 1.308 g/mm^3^, 5965 reflections measured (5.858 ≤ 2Θ ≤ 52.042), 3141 unique (*R*~int~ = 0.0292) which were used in all calculations. The final *R*~1~ was 0.0369 (I \> 2σ(I)) and *wR*~2~ was 0.0852. Crystallographic data have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication number CCDC 1441750. For more information on crystal data, see the Additional files [2](#MOESM2){ref-type="media"} and [3](#MOESM3){ref-type="media"}.Fig. 2The X-ray crystal structure of **10g**

Biological activity {#Sec4}
-------------------

The in vitro fungicidal activities of all the title compounds have been determined against seven pathogenic fungi at the concentration of 50 μg/mL, and the mycelium growth rate method was used \[[@CR35], [@CR36]\]. Pyraclostrobin (Fig. [1](#Fig1){ref-type="fig"}) was assessed as a positive control. The bioassay results, illustrated in Table [1](#Tab1){ref-type="table"}, indicated that the title compounds exhibited obvious fungicidal activities. Most of them displayed satisfied activities against *V. mali*, *S. sclerotiorum* and *G. graminis* var. *tritici*. Particularly, compounds **10d**, **10e**, **10i** and **10j** showed inhibitory activities of more than 85 % against *V. mali*. Compounds **10d**, **10e**, **10f, 10h**, **10i, 10j** and **10l** also demonstrated good activities against *S. sclerotiorum.* Especially, five title compounds (**10d**, **10e**, **10h**, **10i** and **10j**) exhibited striking activities against *G. graminis* var. *tritici*, with more than 90 % inhibition rates.Table 1Fungicidal activities of title compounds against seven kinds of pathogenic fungiCompd.R^1^R^2^Fungicidal activity (%)/50 μg/mL*P. aR. sV. mS. sB. cF. mG. g. t***10a**MeMe5.219.717.833.66.911.84.5**10b**MeEt12.930.714.440.15.715.831.7**10c**Me*i*-Pr12.140.653.072.820.817.08.9**10d**MePh35.162.291.992.674.149.7100**10e**Me4-OMePh25.463.491.584.861.848.5100**10f**Me4-ClPh15.354.757.685.352.327.435.7**10g**PhMe30.626.823.348.428.822.679.0**10h**PhEt40.339.465.784.366.248.599.1**10i**Ph*n*-Pr53.661.086.497.278.954.596.1**10j**Ph*i*-Pr50.456.786.088.079.350.990.1**10k**PhPh12.133.547.572.837.136.287.1**10l**2-ClPhMe20.219.749.688.535.121.078.6**10m**2-ClPh4-ClPh4.822.436.947.936.717.876.4**10n***t*-BuMe17.724.824.632.724.017.026.3**10o**3-ClPyCl24.226.839.845.647.927.065.7**10p**3-ClPyBr38.739.056.859.942.728.672.6Pyraclostrobin----47.410089.010084.578.5100*P. a: Pythium aphanidermatum, R. s: Rhizoctonia solani, V. m: Valsa mali, S. s: Sclerotinia sclerotiorum, B. c: Botrytis cinerea, F. m: Fusarium moniliforme, G. g. t: Gaeumannomyces graminis* var. *tritici*

Primary structure activity relationships (SAR) revealed that the substituents played an important role in fungicidal activities. (1) When substituent R^1^ was methyl, compounds with R^2^ as (substituted) phenyl exhibited better activities than those with R^2^ as alkyl (**10d**, **10e**, **10f** \> **10a**, **10b**, **10c**). (2) When R^1^ was phenyl, the fungicidal activities increased with the increase of the carbon number in the alkyl chain of the R^2^ moiety (**10g** \< **10h** \< **10i** ≈ **10j**). However, fungicidal activities decreased dramatically when R^1^ and R^2^ were both phenyl (**10k**). (3) It was not beneficial to increase their fungicidal activities when R^1^ was substituted pyridyl (**10o** and **10p**).

In particular, compounds **10d** (R^1^ = Me, R^2^ = Ph), **10e** (R^1^ = Me, R^2^ = 4-OMePh), **10i** (R^1^ = Ph, R^2^ = *n*-Pr) and **10j** (R^1^ = Ph, R^2^ = *i*-Pr) exhibited good activities against *V. mali, S. sclerotiorum* and *G. graminis* var. *tritici* with inhibition rates of more than 80 %. Compounds **10d** and **10e** showed comparable activities against *V. mali* and *G. graminis* var. *tritici* with the commercial fungicide pyraclostrobin.

In the further study, fungicidal activities against *G. graminis* var. *tritici* of compounds **10d**, **10e**, **10h**, **10i** and **10j** were evaluated at lower concentrations (Table [2](#Tab2){ref-type="table"}). Obviously, the result revealed a dosage-dependent relationship. Compounds **10d** and **10e** still exhibited satisfied activities with the inhibition rates of 100 % and 94.0 % at the concentration of 16.7 μg/mL, respectively, which is comparable to that of the positive control using pyraclostrobin. Unfortunately, their fungicidal activities decreased dramatically at the concentration of 11.1 μg/mL.Table 2Dosage-dependent in vitro fungicidal activities of **10d**, **10e**, **10h**, **10i**, **10j** and pyraclostrobin against *G. graminis* var. *tritici*Compd.Inhibition rate (%) at different concentrations (μg/mL)50.025.016.711.12.2**10d**10010010065.71.0**10e**10010094.047.7−8.4**10h**99.188.957.137.06.1**10i**96.188.074.363.134.9**10j**90.151.146.037.921.1Pyraclostrobin10010010010092.7

Experimental {#Sec5}
============

Chemistry {#Sec6}
---------

Melting points of all compounds were determined on an X-4 binocular microscope (Fukai Instrument Co., Beijing, China) without calibration. NMR spectra were acquired with a Bruker 300 MHz spectrometer with CDCl~3~ as the solvent and TMS as the internal standard. Chemical shifts are reported in *δ* (parts per million) values. High resolution mass spectrometry (HRMS) data were obtained on an FTICR-MS Varian 7.0T FTICR-MS instrument. Elemental analysis was carried out on a Vario EL III elemental analyzer. All the reagents were obtained commercially and used without further purification. Column chromatography purification was carried out by using silica gel. The synthesis of intermediates and title compounds can be found in the Additional file [1](#MOESM1){ref-type="media"}.

Antifungal biological assay {#Sec7}
---------------------------

All the target compounds have been evaluated for their in vitro fungicidal activities against seven pathogenic fungi, using mycelium growth rate method according to the literature \[[@CR35], [@CR36]\]. Fungi tested in this article included *Pythium aphanidermatum, Rhizoctonia solani, Valsa mali, Sclerotinia sclerotiorum, Botrytis cinerea, Fusarium moniliforme* and G*aeumannomyces graminis* var. *tritici*. Dimethyl sulfoxide (DMSO) in sterile distilled water served as the control. Pyraclostrobin (Fig. [1](#Fig1){ref-type="fig"}) containing pyrazole structure (Fig. [1](#Fig1){ref-type="fig"}) as the commercial fungicide, was assessed under the same conditions as a positive control. In the preparation, every compound (10 mg) was weighted accurately and dissolved in 1 mL DMSO, and then it was mixed with 200 mL potato dextrose agar (PDA). As a consequence, they were tested at a concentration of 50 μg/mL. In order to get new mycelium for antifungal assay, all fungal species were incubated in PDA at 25 ± 1 °C for 1--7 days vary from different fungi. Mycelia dishes were cut with a 5 mm in diameter hole punch from the prepared edge of culture medium. One of them was picked up with a sterilized inoculation needle, and then inoculated in the center of the PDA plate aseptically. Every treatment repeated three times, and they were incubated at 25 ± 1 °C for 1--7 days vary from different fungi. All the above was completed in a bioclean environment. The hypha diameter was measured by a ruler, and the data were statistically analyzed. The inhibition rate of the title compounds on the fungi was calculated by the following formula:

I (%) = \[(C − T)/(C − 5)\] × 100, where I is the inhibition rate, C represents the diameter (mm) of fungal growth on untreated PDA, and T represents the diameter (mm) of fungi on treated PDA.

Conclusion {#Sec8}
==========

In summary, a series of pyrazole derivatives containing 1,2,3,4-tetrahydroquinoline were synthesized and their structures were confirmed by ^1^H NMR, ^13^C NMR, IR and HRMS or elemental analysis. The crystal structure of compound **10g** was determined by X-ray diffraction. Bioassay results indicated that all the title compounds exhibited good fungicidal activities. And the substituents played an important role in fungicidal activities. In particular, compounds **10d** and **10e** with simple structures showed comparable activities against *G. graminis* var. *tritici* to the commercial fungicide pyraclostrobin even at the concentration 16.7 μg/mL. These two compounds could be valuable leads for further studies.
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